Table 2.
Peripheral blood CD34+ cell and WBC count kinetics in response to plerixafor salvage in patients with extremely low baseline CD34+ cell counts.
| PB counts (/μL) | Baseline | Post P dose no. 1 | Post P dose no. 2 | Post P dose no. 3 | Post P dose no. 4 | Post P dose no. 5 | Post P dose no. 6 | Post P dose no. 7 | Post P dose no. 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Patient #1 | WBC | 28.5 | 25.8 | 24.7 | 27.3 | 43.3 | ||||
| CD34+ | 1 | 1 | 1 | 2 | 4 | |||||
|
| ||||||||||
| Patient #2 | WBC | 14 | 22.6 | 26.2 | 28.9 | 31.3 | 34.1 | 38.4 | 46.1 | |
| CD34+ | 1 | 2 | 2 | 4 | 4 | 6 | 7 | 11 | ||
|
| ||||||||||
| Patient #3 | WBC | 4.1 | 10.6 | 14.7 | 14.8 | 17.1 | 18.6 | 20 | 22.7 | 27 |
| CD34+ | 0 | 3 | 4 | 3 | 3 | 8 | 9 | 6 | 12 | |
|
| ||||||||||
| Patient #4 | WBC | 19.4 | 51.6 | 60.8 | 58.8 | 58.1 | 66.9 | 80.1 | ||
| CD34+ | 0 | 3 | 2 | 4 | 4 | 13 | 13 | |||
P = plerixafor; PB = peripheral blood; WBC = white blood cell count.